APA

Fiala O., Hosek P., Pesek M., Finek J., Racek J., Buchler T., Poprach A., Hejduk K., Chloupkova R., Sorejs O., Ecksteinova M., Vitovec M., Cizkova K., Kucera R. & Topolcan O. (20190425). Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed. : Neoplasma.

Chicago

Fiala O, Hosek P, Pesek M, Finek J, Racek J, Buchler T, Poprach A, Hejduk K, Chloupkova R, Sorejs O, Ecksteinova M, Vitovec M, Cizkova K, Kucera R and Topolcan O. 20190425. Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed. : Neoplasma.

Harvard

Fiala O., Hosek P., Pesek M., Finek J., Racek J., Buchler T., Poprach A., Hejduk K., Chloupkova R., Sorejs O., Ecksteinova M., Vitovec M., Cizkova K., Kucera R. and Topolcan O. (20190425). Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed. : Neoplasma.

MLA

Fiala O, Hosek P, Pesek M, Finek J, Racek J, Buchler T, Poprach A, Hejduk K, Chloupkova R, Sorejs O, Ecksteinova M, Vitovec M, Cizkova K, Kucera R and Topolcan O. Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed. : Neoplasma. 20190425.